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SUMMARY Using monoclonal antibodies Tal and CD25 (interleukin-2 receptor: I-2R) and flow cytometry, the levels of activated lymphocytes in the peripheral blood of 50 patients with multiple sclerosis (16 relapsing inactive; 14 relapsing active; 20 chronic progressive) and 20 normal subjects were investigated. No significant differences were observed in the percentage or absolute numbers of Ta I and IL-2R reactive lymphocytes between the normal and multiple sclerosis patient groups, irrespective of disease activity. Monitoring peripheral blood lymphocytes with respect to these markers would appear to and normal controls (data not shown).
Discussion
In this study we did not observe differences in Tal reactivity in peripheral blood lymphocytes from Low levels of IL-2R lymphocytes were observed in peripheral blood of both normal donors and multiple sclerosis patients. This is a consistent finding in multiple sclerosis where increases in IL-2R+ cells are negligible or modest.9 -113 However, significantly elevated numbers of IL-2R+ cells can be demonstrated in the CSF.
III Whether this reflects local activation within the CSF or recruitment from the periphery is unclear at present.
In conclusion, using two markers of lymphocyte activation (Tal, IL-2R) we were unable to demonstrate abnormal levels of activated cells in the peripheral blood of multiple sclerosis patients irrespective of disease activity. The clinical relevance of activated T cells and their role in the pathogenesis of multiple sclerosis remain to be determined. Nevertheless future studies using additional activation markers and determination of the functional characteristics of these cells may still help to further elucidate this aspect of the immunological process in multiple sclerosis.
